Get startedLog in
    Picture of High Tech Pharm Co logo

    106190 — High Tech Pharm Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for High Tech Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-1,2254,0289,86417,08713,828
    Depreciation
    Non-Cash Items1,5922,2121,8981,9811,935
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital1,011-15,488-13,839-9,546-4,152
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities6,928-3,7032,90914,69117,028
    Capital Expenditures-860-656-5,091-2,133-1,926
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-4321,386-1,664990-651
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-1,292730-6,755-1,143-2,577
    Financing Cash Flow Items———194—
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities4,621-390-529-9,416-9,031
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash10,237-3,394-4,3984,2765,317